
Keywords: ژرانیلگرانیول; Apo; apolipoprotein; ATX; astaxanthin; DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; GG; geranylgeraniol; HDL-C; high-density lipoprotein cholesterol; ITT; intent to treat; LDL; low-density lipoprotein; LDL-C; low-density lipoprotein cholesterol;